Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Carcinoma Stage IV”

540 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 540 results

Large-scale testing (Phase 3)Study completedNCT00255606
What this trial is testing

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Tampere University 360
Very early researchUnknownNCT04113096
What this trial is testing

Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer

Who this might be right for
Stage IV Prostate CancerStage IV Colon CancerStage IV Breast Cancer+1 more
The University of The West Indies 104
Not applicableEnded earlyNCT00002668
What this trial is testing

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Who this might be right for
Breast CancerPainProstate Cancer
Eastern Cooperative Oncology Group 13
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Not applicableStudy completedNCT01120262
What this trial is testing

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 545
Early research (Phase 1)UnknownNCT00009750
What this trial is testing

Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, Davis
Early research (Phase 1)Active Not RecruitingNCT02023463
What this trial is testing

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
Thomas Jefferson University 25
Post-approval studies (Phase 4)Ended earlyNCT01673984
What this trial is testing

GP Extended Action Triptorelin

Who this might be right for
Prostate Cancer
Ipsen 27
Early research (Phase 1)WithdrawnNCT03477864
What this trial is testing

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Who this might be right for
Stage III Prostate CancerStage IIIA Prostate CancerStage IIIB Prostate Cancer+4 more
Sidney Kimmel Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Early research (Phase 1)Study completedNCT00482807
What this trial is testing

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 9
Not applicableStudy completedNCT00685516
What this trial is testing

Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 113
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00025194
What this trial is testing

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00176605
What this trial is testing

Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 15
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00337077
What this trial is testing

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-refractory Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 121
Load More Results